Concord Biotech shares listed with a gain of 21 percent on the issue price
[ad_1]
The company’s scrip rose 21.46 per cent to Rs 900.05 in early trade on the BSE. Later it was trading at Rs 916, up 23.61 per cent. The company’s stock got listed at Rs 900.05 on the National Stock Exchange.
New Delhi. Shares of Concord Biotech got listed on the bourses on Friday at its issue price of Rs 741, up 21 per cent. The company’s scrip rose 21.46 per cent to Rs 900.05 in early trade on the BSE. Later it was trading at Rs 916, up 23.61 per cent. The company’s stock got listed at Rs 900.05 on the National Stock Exchange.
Later, it gained 23.73 per cent to Rs 916.90. The company’s initial public offering (IPO) was subscribed 24.86 times last week. The price range for the company’s Rs 1,550.59 crore IPO was Rs 705 to Rs 741 per share. The Rare Enterprises-backed Concorde’s IPO was a full-fledged offer for sale (OFS).
Disclaimer: IndiaTheNews has not edited this news. This news has been published from PTI-language feed.
other news
[ad_2]
Source link